Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $14,038 - $15,383
-100 Reduced 3.57%
2,700 $402,000
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $33,342 - $46,197
-300 Reduced 9.68%
2,800 $367,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $25,500 - $29,288
200 Added 6.9%
3,100 $453,000
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $50,780 - $56,855
400 Added 16.0%
2,900 $376,000
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $65,575 - $72,120
500 Added 25.0%
2,500 $349,000
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $226,296 - $251,622
1,800 Added 900.0%
2,000 $280,000
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $24,568 - $29,568
200 New
200 $26,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.